News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
How the international nature of science makes him feel at home – The Nobel Prize
Photo taken from The Nobel Prize/LinkedIn
Jan 30, 2024, 14:37

How the international nature of science makes him feel at home – The Nobel Prize

The Nobel Prize posted on LinkedIn:

“”I found my tribe. The tribe of science.”

At our Nobel Week Dialogue on migration, medicine laureate Ardem Patapoutian spoke about how the international nature of science makes him feel at home.

Watch more.”

Source: The Nobel Prize/LinkedIn

Ardem Patapoutian cancer Nobel Week Dialogue OncoDaily Oncology The Nobel Prize The tribe of science
Special Coverage
Insight
Aug 31, 2024, 12:58
Eric Singhi: Our editorial in ASCO Daily News on the CHOICE-01 study
Blog
Aug 31, 2024, 12:55
Simple steps you can follow to reduce your cancer risk at any age by Arif Kamal - ACS
Insight
Aug 31, 2024, 12:49
New Insights on Psilocybin's Impact on the Human Brain by Joshua Siegel et al.
Blog
Aug 31, 2024, 12:46
Honoring Steve Abbott, Executive Director of Cincinnati Cancer Advisors
Blog
Aug 31, 2024, 11:09
Edward D. Esplin: Clinician Responses to Germline Genetic Testing in Prostate Cancer Management
Blog
Aug 31, 2024, 10:53
OncoInfluencers to Follow on Social Media: Dr. Fabio Ynoe de Moraes
Insight
Aug 31, 2024, 10:03
Myeloma Paper of the Day, August 31st, suggested by Robert Orlowski
Insight
Aug 31, 2024, 09:52
Article of the day, August 31st, suggested by the Immune Oncology Research Institute
Blog
Aug 31, 2024, 09:47
Christian Rolfo: Excellent educational experience at Swiss Oncology Summer School
Insight
Aug 31, 2024, 09:45
Piotr Wysocki: Older patients with mCRC receiving fluoropyrimidine+bevacizumab do not gain additional benefit from adding oxaliplatin
Blog
Aug 31, 2024, 09:41
Miriam Mutebi: Children's lives cut short by cancer is a tragedy we can't ignore
Insight
Aug 31, 2024, 09:08
Vivek Subbiah: Our commentary on Precision oncology across the ages